Gavel and buds Cannabis Dispensary Tourism

From Schedule 1 to Schedule 3: Exploring the Potential Impact of Cannabis Reclassification

In a landmark development, the US Department of Health and Human Services (HHS) has recently recommended a significant change in the scheduling of cannabis, proposing to move it from a Schedule 1 drug to a Schedule 3 drug. This recommendation has sparked debates and discussions across the nation about the potential implications of such a shift. In this blog, we will delve into the intricacies of drug scheduling, the actors involved, the significance of this change, and the pros and cons associated with the de-scheduling of cannabis.

How are drugs currently scheduled through the Controlled Substance Act?

The scheduling of drugs in the United States is governed by the Controlled Substances Act (CSA) of 1970, which classifies substances into five schedules based on their perceived medical utility, potential for abuse, and safety. Schedule 1 is the most restrictive category, while Schedule 5 is the least restrictive. Currently, cannabis is classified as a Schedule 1 drug, indicating that it is considered to have a high potential for abuse, no accepted medical use, and a lack of accepted safety for use under medical supervision.

Schedule 1

Schedule 1, where cannabis currently resides, is a classification that places it alongside substances like heroin and LSD. This classification has long been a point of contention in the United States, as it places cannabis in the same category as drugs that are widely recognized as highly addictive and dangerous with no accepted medical use.

Schedule 2

Schedule 2 drugs, on the other hand, include substances like cocaine and opioids, which are acknowledged to have some medical applications but are subject to strict regulations due to their potential for abuse and addiction. The placement of cannabis in Schedule 1 has been a barrier to conducting extensive research into its medical potential, as it imposes stringent restrictions on obtaining research permits and funding for studies.

Schedule 3

Schedule 3 drugs, such as certain anabolic steroids and medications like Vicodin, are recognized as having a moderate to low potential for abuse and accepted medical uses. The proposed move of Cannabis from Schedule 1 to Schedule 3 signifies a significant shift in how cannabis is perceived by federal authorities.

Schedule 4

Schedule 4 drugs are substances that have a lower potential for abuse relative to Schedule 1, 2, and 3 drugs, but they still carry a risk of physical or psychological dependence. These substances have accepted medical uses and are commonly prescribed by healthcare professionals. Schedule 4 drugs include medications such as Xanax (alprazolam), Ativan (lorazepam), and Valium (diazepam), which are primarily used to treat anxiety and panic disorders. They are subject to regulations to minimize the potential for misuse or diversion.

Schedule 5

Schedule 5 drugs are the least restrictive category under the CSA. These substances have a very low potential for abuse relative to the higher schedules and are primarily used for medicinal purposes. Schedule 5 drugs include medications like cough preparations containing less than 200 milligrams of codeine per 100 milliliters or per 100 grams (Robitussin AC, Phenergan with Codeine) and medications containing low doses of opiate medications for antidiarrheal purposes (Lomotil, Motofen).

Unlike Schedule 1 and 2 drugs, which are subject to strict regulations and oversight, Schedule 4 and 5 drugs are more readily available with a prescription from a licensed healthcare provider. The primary focus with these schedules is to ensure that these substances are used for legitimate medical purposes while minimizing the risk of abuse and dependence.

What are the steps to take this from a simple recommendation to legally making Cannabis a Schedule 3 drug?

Recommendations are a great first step but a far cry from actually rescheduling Cannabis. In order to do that, we have to understand the steps involved and who ultimately makes those decisions. The process of rescheduling a controlled substance like cannabis is a multi-step, thorough, and often lengthy process, with the Drug Enforcement Administration (DEA) holding the ultimate authority for making this decision.

  1. HHS Recommendation: The initial step in the rescheduling process begins with the recommendation from the US Department of Health and Human Services (HHS). This recommendation is pivotal, as it is based on comprehensive evaluations of scientific, medical, and public health data. The HHS analyzes research findings, reviews existing literature, and consults with experts to determine whether the current scheduling of a substance aligns with its potential for abuse, medical utility, and safety.
  2. DEA Evaluation: Once the HHS makes its recommendation, it is then forwarded to the Drug Enforcement Administration (DEA). The DEA is responsible for enforcing the Controlled Substances Act and has the authority to reschedule or reschedule controlled substances. Upon receiving the recommendation, the DEA conducts its own exhaustive review.
  3. Rigorous Assessment: The DEA’s review process involves a rigorous examination of the scientific and medical evidence surrounding the substance in question. This includes scrutinizing studies, clinical trials, anecdotal evidence, and any potential risks associated with the substance’s use. The agency also takes into account public comments and feedback during this process, allowing for a comprehensive evaluation from various stakeholders.
  4. Final Determination: After the DEA has completed its review, it makes the final determination regarding the scheduling of the substance. This decision can involve maintaining the current schedule, rescheduling to a different schedule, or de-scheduling the substance entirely. The DEA’s decision is based on its assessment of the evidence and whether the substance’s current classification aligns with scientific understanding and public health considerations.

How the decision is made

It’s important to note that the DEA’s decision-making process is intended to be impartial and based on scientific evidence rather than political or ideological factors. However, the process can be influenced by changing attitudes, new research findings, and evolving public perceptions.

In the case of cannabis, the HHS’s recommendation to move it from Schedule 1 to Schedule 3 reflects a significant shift in how the federal government views the plant. If the DEA were to concur with this recommendation, it would signal a change in federal policy that could have far-reaching implications for medical research, patient access, and the legal status of cannabis in the United States. As the evaluation process unfolds, it will be closely watched by individuals, researchers, and stakeholders who have a vested interest in the future of cannabis regulation. The fact is, we are only at the tip of the iceberg when it comes to the actual rescheduling of Cannabis.

Why does this change matter, what does it represent?

There are many ways rescheduling or completely de-scheduling Cannabis could change the lives of the American people. Here are just a few options to expand on when considering how opening up Cannabis and making it available to all, might be helpful.

Access to Medical Marijuana:

The reclassification of cannabis from Schedule 1 to Schedule 3 holds the promise of transforming the landscape of medical marijuana in the United States. Currently, the Schedule 1 classification severely limits scientific research into the potential medical benefits of cannabis. Researchers face numerous hurdles in obtaining research permits, funding, and access to a consistent supply of cannabis for studies. This hinders our understanding of the plant’s therapeutic potential and limits the development of new treatments.

By moving cannabis to a lower schedule, the federal government could signal its commitment to advancing medical research. This could lead to more comprehensive studies on cannabis and its various compounds, such as CBD and THC, potentially unlocking new treatments for a wide range of medical conditions. Patients suffering from chronic pain, epilepsy, multiple sclerosis, and other ailments could see improved access to evidence-based treatments that incorporate cannabis derivatives.

Reduced Criminal Penalties:

The criminalization of cannabis has led to countless arrests and convictions, disproportionately affecting communities of color. De-scheduling cannabis could result in a significant reduction in criminal penalties for possession and use. Individuals with non-violent cannabis-related offenses may no longer face the severe legal consequences that often result in lifelong barriers to employment, housing, and education.

Furthermore, the burden on the criminal justice system, including law enforcement, courts, and prisons, would be alleviated. This could free up resources to focus on more pressing matters and contribute to a more equitable and efficient justice system.

Economic Impact:

The cannabis industry has experienced remarkable growth in states where it has been legalized for either medical or recreational use. A shift from Schedule 1 to Schedule 3 would likely lead to reduced regulatory restrictions, potentially fueling further economic growth and job creation.

Legalizing and regulating the cannabis industry at the federal level could open up opportunities for legitimate businesses to thrive, resulting in increased tax revenue for local and state governments. It could also create a broader range of job opportunities, from cultivation and distribution to retail and research roles, benefiting local economies.

The proposed rescheduling of cannabis carries significant ramifications for multiple stakeholders. From patients seeking effective medical treatments to researchers aiming to uncover the full therapeutic potential of cannabis compounds, the potential for change is substantial. Simultaneously, a shift in scheduling could lead to reduced criminal penalties and offer economic benefits, particularly for the burgeoning cannabis industry. As the debate over cannabis policy continues to evolve, it remains a critical topic that will shape the future of healthcare, justice, and the economy in the United States.

What are the pros and cons of de-scheduling cannabis?


  • Research Advancements: Rescheduling could facilitate further research into the potential medical benefits of cannabis, potentially leading to new treatments and therapies.
  • Criminal Justice Reform: De-scheduling could lead to a reduction in arrests and convictions related to cannabis possession, reducing the strain on the criminal justice system.
  • Economic Benefits: A less restrictive schedule could stimulate economic growth by allowing for expanded cultivation, distribution, and sales of cannabis products.


  • Safety Concerns: Critics argue that de-scheduling may lead to increased access to cannabis, potentially raising concerns about misuse, impaired driving, and public health risks. Education will be key in both gaining the public’s trust over a plant that has long since been associated with other Schedule 1 drugs as well as ensuring safe usage and proper dosing in what is certainly an ever evolving landscape of modern cannabis consumption.
  • Federal vs. State Conflicts: Cannabis is legal for medical or recreational use in many states, but federal prohibition persists. Rescheduling may not fully resolve the conflict between state and federal laws. Beyond that, What does taxation for the states look like after a rescheduling and potentially legalization of cannabis?
  • Regulatory Challenges: The transition from Schedule 1 to a lower schedule could pose regulatory challenges, including product quality control, taxation, and marketing restrictions. Right now, we handle this well on a state-to-state level, but if the government federally legalizes cannabis after rescheduling, all the growing pains we went through to get seed-to-sale tracking systems in place might have to happen all over again.

To be clear, the HHS recommendation to reschedule cannabis from a Schedule 1 to a Schedule 3 drug really does mark a significant development in the ongoing debate over cannabis policy in the United States. And while it could offer numerous benefits such as expanded research opportunities and criminal justice reform, it also raises concerns about public safety and regulatory complexities. The final decision by the DEA will shape the future of cannabis in the United States, affecting the lives of millions of Americans and the trajectory of the cannabis industry. Stay tuned for updates as this important issue unfolds.

Here are a few sources about rescheduling Cannabis that you might find interesting:

  1. National Institute on Drug Abuse (NIDA) – Marijuana as Medicine: This government resource provides information on the current state of research and policies regarding the medical use of cannabis. It offers insights into the scientific aspects of cannabis and its potential therapeutic benefits.
  2. The Brookings Institution – “The medical marijuana mess: A prescription for fixing a broken policy”: This report delves into the complex issues surrounding the scheduling of cannabis and offers policy recommendations for a more rational approach to cannabis in the United States.
  3. Drug Enforcement Administration (DEA) – Controlled Substances Act: The DEA’s website provides information on the Controlled Substances Act, which governs the scheduling of drugs in the United States. It offers details on the legal framework and criteria used for drug scheduling decisions.
  4. NORML – National Organization for the Reform of Marijuana Laws: NORML is an advocacy group focused on cannabis policy reform. Their website offers a wealth of information on cannabis-related issues, including updates on legislative changes and advocacy efforts.
  5. PubMed – Cannabis Research: For those interested in scientific studies and research articles on cannabis, PubMed is a valuable resource. It provides access to a vast collection of peer-reviewed research papers related to the medical and therapeutic aspects of cannabis.

Substance Market is Here For You!

Stop into any of our stores to check our some of our products. You can also check any of our menus here.

Additionally, you can find more information on the vendors we work with here.

Substance offers online ordering and curbside pickup for dabs and other fine products at all dispensary locations throughout Bend, OR, off I-5 in Cottage Grove, OR, and now at our newest location in Springfield, OR.

full spectrum cannabis

Full Spectrum Cannabis

What is full spectrum cannabis?

Full spectrum products come from the whole cannabis plant, including all naturally occurring cannabinoids, terpenes, and other plant compounds. This means that they contain a wide range of different chemical compounds, each with their own unique properties and potential health benefits.

In contrast to isolated cannabinoids or refined cannabis extracts, full spectrum products aim to preserve the natural complexity and synergy of the cannabis plant. This is because research suggests that these compounds work together in the “entourage effect,” which means that they can enhance each other’s effects and provide a more complete and well-rounded therapeutic experience.

Full spectrum cannabis products often contain a significant amount of THC, which is the primary psychoactive compound in cannabis, as well as other cannabinoids such as CBD, CBG, and CBN. They also contain a variety of terpenes, which are aromatic compounds that give cannabis its distinctive smell and taste, and may also have their own unique health benefits.

Overall, full spectrum cannabis products has shown to be one of the most natural and effective form of cannabis medicine. This may be because they offer a broad range of therapeutic effects. Full spectrum may be more effective than isolated compounds or synthetic alternatives.

full spectrum cannabis
Photo Credit Flikr

What are some examples of full spectrum cannabis products?

Full spectrum CBD oil

For CBD oil to be considered full spectrum, it must contain all naturally occurring cannabinoids, terpenes, and other plant compounds found in the hemp plant, including a significant amount of CBD.

Full spectrum THC oil

This product contains all naturally occurring cannabinoids, terpenes, and other plant compounds found in the marijuana plant, including a significant amount of THC.

Live resin

Live resin is a type of cannabis extract made from freshly harvested, flash-frozen cannabis flowers. This preserves the full spectrum of cannabinoids and terpenes, resulting in a highly aromatic and flavorful product.

Rick Simpson Oil (RSO)

This is a type of cannabis oil created by using a full spectrum extraction process. This involves soaking the cannabis plant in a solvent such as ethanol or butane to extract all the plant compounds. The resulting oil contains a full spectrum of cannabinoids and terpenes, including THC and CBD.

Whole-plant cannabis

This is the most basic form of full spectrum cannabis, which involves using the entire plant, including the flowers, leaves, and stalks. This is often used for making cannabis-infused edibles or as a raw material for other types of cannabis extracts.

What is not considered full spectrum cannabis?

Full spectrum cannabis products contain a range of cannabinoids, terpenes, and other plant compounds, whereas other cannabis products may be more refined and contain only specific cannabinoids or other components. Here are some examples of cannabis products that are not considered full spectrum:

Cannabis isolate

As mentioned earlier, cannabis isolate is a pure form of cannabis extract that contains only one cannabinoid compound, usually either THC or CBD.

Broad-spectrum cannabis products 

Broad-spectrum cannabis products contain multiple cannabinoids and terpenes, but with the THC component removed. This is often done to produce a product with the benefits of multiple cannabinoids, but without the psychoactive effects of THC.

THC distillate

THC distillate is a highly concentrated form of THC with an absence of all other compounds. This results in a pure, potent form of THC that with endless applications.

CBD isolate

Similar to cannabis isolate, CBD isolate is a pure form of CBD extract that contains only the CBD cannabinoid, with all other components removed.

Hemp Seed oil

Pressing the seeds of the hemp plant creates hemp seed oil, and contains no cannabinoids. It is often used as a carrier oil for other cannabis extracts, but is not considered a full spectrum product.

What is cannabis distillate?

A cannabis distillate is a highly concentrated form of cannabis extract produced using a distillation process. This process removes all impurities and unwanted compounds from the cannabis plant, leaving behind a pure, potent product with a high level of THC or CBD.

During the distillation process, the cannabis extract undergoes heating, then cooling, causing the different compounds to separate based on their boiling points. The resulting distillate is then further processed to remove any remaining impurities, resulting in a clear, colorless liquid with a very high potency.

Cannabis distillates are often used in the production of cannabis-infused products such as edibles, tinctures, and vape cartridges, as they can provide a consistent and precise dose of THC or CBD. They are also sometimes used for dabbing, a method of vaporizing and inhaling cannabis concentrates.

Read our article on distillate here.

cannabis isolate
Photo Credit WikiLeaf

What is cannabis isolate?

Cannabis isolate is a pure form of cannabis extract that contains only one cannabinoid compound, usually either THC or CBD. Creating an isolate involves isolating and refining a specific cannabinoid from a full-spectrum cannabis extract, which contains a range of cannabinoids, terpenes, and other plant compounds.

Isolating a cannabinoid involves further refining the full-spectrum extract to remove all other compounds except for the desired cannabinoid. This results in a highly concentrated form of the cannabinoid, often in the form of a white crystalline powder or a clear liquid.

Cannabis isolate is commonly used in the production of cannabis-infused products such as tinctures, edibles, and vape cartridges, as it allows for precise dosing and consistent effects. Cannabis isolate is often used in the production of cannabis-infused products such as tinctures, edibles, and vape cartridges, as it allows for precise dosing and consistent effects. Isolate is also used to create custom cannabis blends. 

Check out this documentary from PBS for more information.

What are the benefits of full spectrum cannabis versus not?

Full spectrum cannabis products contain a wide range of cannabinoids, terpenes, and other plant compounds. Non-full spectrum products are typically more refined and may contain only specific cannabinoids or other components. Here are some potential benefits of full spectrum cannabis products compared to non-full spectrum products:

Entourage effect

Cannabis products contain different cannabinoids and terpenes that work together to produce the entourage effect. This means that these compounds can enhance each other’s effects and provide a more complete and well-rounded therapeutic experience.

More complete therapeutic experience

Due to the range of different compounds, full spectrum products may provide a more complete therapeutic experience. This may be especially true for conditions that require a range of different cannabinoids and terpenes to be effective.

Potentially more effective

Some research suggests that full spectrum products may be more effective than isolated compounds or synthetic alternatives. This may be due to the entourage effect and other factors.

Less processed

Full spectrum products are typically less processed than non-full spectrum products. This is because they contain the whole cannabis plant. This may be beneficial for people who prefer a more natural and holistic approach to cannabis medicine.

More natural flavor and aroma

Full spectrum products often have a more natural flavor and aroma than non-full spectrum products. This is because of their high content of different terpenes and other plant compounds. This contributes to the overall taste and smell of the product.

What are the benefits of non-full spectrum products?

Non-full spectrum products do not contain the full range of compounds found in the whole cannabis plant. Here are some potential benefits of non-full spectrum cannabis products compared to full spectrum products:

Precise dosing

These types of products can allow for more precise dosing of specific cannabinoids, such as CBD or THC. This can be especially useful for people who require a specific dose of a particular cannabinoid for their condition.

Reduced psychoactive effects

Isolated cannabinoid products may be beneficial for people who are sensitive to the psychoactive effects of THC. Many of these products can contain higher levels of other cannabinoids such as CBD, CBG, or CBN.


Broad spectrum cannabis products can be more consistent in terms of cannabinoid content and quality. They are often produced under more controlled conditions.


Oftentimes, products without a broad spectrum of cannabinoids can be more convenient to use than full spectrum products. This is because they may be available in more standardized forms such as capsules, tinctures, or topical creams.

No risk of contamination

Isolated products may be less likely to contain contaminants such as pesticides or heavy metals. This is because they are often produced under more controlled conditions and with higher standards of quality control.

Note that non-full spectrum products may not provide the same range of therapeutic benefits as full spectrum products. This is due to the lack of the entourage effect and other factors. As with any cannabis product, the right product depends on individual needs and preferences. As always consult with a healthcare professional.

How to make full spectrum products at home


Before making any cannabis product, you need to decarboxylate your cannabis, which is the process of heating it to activate the cannabinoids. To do this, preheat your oven to 220-240°F (105-115°C). Grind your cannabis and spread it evenly on a baking sheet. Bake for 30-45 minutes, stirring occasionally, until it is lightly browned and fragrant.


The simplest method for making full spectrum cannabis products at home without the use of solvents involves infusing a carrier oil such as coconut, olive, or MCT oil with decarboxylated cannabis. Start by placing the cannabis and oil in a mason jar and heating it in a water bath or slow cooker for several hours, then straining out the plant material. This will produce a full spectrum cannabis oil. Uses for this are endless.


Once you have your full spectrum cannabis oil, you can use it to make a variety of different products, such as edibles, tinctures, or topicals. For edibles, you can simply mix the oil with a fat such as butter or oil and use it in your favorite recipe. For tinctures, you can mix the oil with a high-proof alcohol such as Everclear and let it steep for several weeks, then strain out the plant material. For topicals, you can mix the oil with a carrier oil such as coconut or olive oil and use it as a massage oil or skin balm.

What are some products designed to help make cannabis oil?

There are several products on the market that are specifically designed to help make cannabis oil. Here are a few examples:

MagicalButter Machine

This countertop appliance infuse herbs into butter, oil, and tinctures. It has a built-in heating unit and a blender that agitates the mixture to help extract the active ingredients from the cannabis plant.

Source Turbo

Source Turbo is a compact vacuum distillation unit that quickly and efficiently extract essentials oils from herbs, including cannabis. It uses a low-heat distillation process to preserve the integrity of the plant compounds.

Ardent Nova

The Ardent Nova is a decarboxylator that activates the cannabinoids in cannabis without burning the plant material. The Ardent Nova can decarboxylate and infuse cannabis into oil or butter for edibles and topicals.

Rosin Press

A rosin press uses heat and pressure to extract cannabis oil from the plant material. It is a popular option for those who prefer solventless extraction methods.

Infusion Kits

Many companies sell infusion kits that include all the necessary tools and instructions for making cannabis oil at home. These kits typically include items such as a decarboxylator, infusion bags, and a cooking vessel.

Here are a few books about full spectrum cannabis that you might find interesting:

“The Cannabis Manifesto: A New Paradigm for Wellness” by Steve DeAngelo

DeAngelo explores the medicinal and therapeutic properties of cannabis and makes the case for full spectrum cannabis as the most effective form of treatment.

“Cannabis Pharmacy: The Practical Guide to Medical Marijuana” by Michael Backes

Backes provides an in-depth look at the different strains of cannabis and their medicinal properties. It also includes a section on full spectrum cannabis and its benefits for treating specific conditions.

“The Medical Cannabis Guidebook: The Definitive Guide to Using and Growing Medicinal Marijuana” by Jeff Ditchfield 

Ditchfield’s comprehensive guide to using and growing cannabis for medicinal purposes. It includes a section on full spectrum cannabis and its potential as a treatment for a variety of medical conditions.

Substance Market is Here For You!

Stop into any of our stores to check our some of our products. You can also check any of our menus here.

Additionally, you can find more information on the vendors we work with here.

Substance offers online ordering and curbside pickup for dabs and other fine products at all dispensary locations throughout Bend, OR and now at our newest location in Cottage Grove, OR.

Cold and Heated Cannabis Extractions

Medical cannabis is processed for administration in various ways; fresh, dried, and cold/heated extractions (or concentrates). In this session of the Substance Cannabis Class, we will be covering the different forms of cold and heated extractions.

Cold extractions/concentrates result in various products: 

  1. Kief: Powder of the trichomes that have fallen off the plant. May be ingested raw but is usually smoked on top of flower buds or ingested in cooked edibles.
  2. Slurry: Extraction using olive oil or alcohol. Usually ingested raw.
  3. Hash: Extraction using cold water and ice. May be ingested raw, smoked or used in cooking. Variety names reflect differences in the proportion of plant material to trichomes and how the variety reacts to heat.
    • Bubble = initially bubbles when exposed to heat.
    • Full bubble = continues to bubble throughout the heating process.
    • Melt = melts or turns into gooey oil when exposed to heat.
    • Full melt = almost pure trichomes; fully melts when exposed to heat, leaving little or no residue.
  4. Wax: Extraction using a solvent, most commonly butane, propane, CO2 or O2. Removal (“purging”) of the solvent may be through cold or heat evaporation (which changes the compounds available). Waxes are usually burned or vaporized, but may be used in cooking and in topical salves. Variety names usually refer to consistency. Examples:
    • Honeycomb/Crumble = dry, crumbly texture; often has small holes like a honeycomb.
    • Budder = more viscous, consistency like butter.
    • Shatter/Glass = consistency similar to hard candy.
    • Sap = sticky texture similar to honey.
    • Taffy = firmer than sap but not brittle like shatter.

Heated extractions/concentrates convert the cannabinoid acids into their neutral forms and usually removes most of the terpenoids. Various products include: 

  1. Tea: Extraction into hot water and then drunk.
  2. Tincture: Heated cannabis that is extracted in alcohol. Usually administered directly under the tongue (sublingually).
  3. Edible: Extraction into a fat (butteroil) and then used in cooking food.
  4. Oil: Slow heating of cannabis in olive or coconut oil. Usually used in food or topically on skin.
  5. Salve/Cream/Lotion: Low heating of cannabis oil with beeswax. Used topically on skin.

What Are Cannabinoids?

The Cannabis Sativa plant is known to produce over 480 chemical compounds. This includes over 100 known phytocannabinoids, commonly referred to as cannabinoids, that have not been found in any other plant. Cannabinoids can be used to treat a variety of ailments, long-term illnesses and diseases. They are known to mitigate the side-effects of heavy prescription drug use.

THC, CBD and CBN are the most tested and researched cannabinoids found in the Cannabis Sativa plant.

THC: Delta-9 Tetrahydrocannabinol (THC) is the primary psychoactive component of cannabis.

– How can it help me?  THC moderates pain, stimulates appetite, and reduces vomiting and nausea. It alleviates contractions in the lower intestine and suppresses muscle spasms.

CBD: Cannabidiol (CBD) is a primarily non-psychoactive cannabinoid.

– How can it help me? CBD, in addition to alleviating the symptoms listed above, treats psoriasis, reduces risk of artery blockage, slows bacterial growth, and relieves neuropathic pain in patients. Research now shows it can inhibit cancer growth.

CBN: Cannabinol (CBN) is a product of THC oxidation and forms after the harvested plant is exposed to oxygen.

– How can it help me? CBN is known to help alleviate insomnia and muscle spasms, as well as relieve pain.

While the aforementioned cannabinoids are currently the most researched, they are not necessarily the most important. Other cannabinoids, such as Cannabigerol (CBG) and Cannabichromene (CBC) work with the other cannabinoids to provide overall synergy and to optimize the health benefits of cannabis itself.